Weekly Recap: Epcoritamab Phase III readout and DKK 44.3m share issuance
Genmab A/S Sponsored ADR (OMXCOP:GMAB) said a pivotal Phase III readout for epcoritamab in first-line DLBCL is due next quarter while the company issued 28,011 new shares after employee warrant exercises, raising ~DKK 44.3m and making the shares transferable and dividend-eligible.Previous Week Reca…